Cargando…

Responsive Dual-Targeting Exosome as a Drug Carrier for Combination Cancer Immunotherapy

Recently, combination immunotherapy, which incorporates the activation of the immune system and inhibition of immune escape, has been proved to be a new powerful strategy for more efficient tumor suppression compared to monotherapy. However, the major challenge is how to integrate multiple immune dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yuanyuan, Zhou, Yingshun, Lu, Meng, Si, Haibin, Li, Lu, Tang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AAAS 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426567/ https://www.ncbi.nlm.nih.gov/pubmed/34541546 http://dx.doi.org/10.34133/2021/9862876

Ejemplares similares

Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
por: Saleh, Reem, et al.
Publicado: (2020)

Combinational antitumor strategies of exosomes as drug carriers: Mini review
por: Xiao, Guixiu, et al.
Publicado: (2023)

Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
por: Yong, Tuying, et al.
Publicado: (2019)

Exosome-Based Carrier for RNA Delivery: Progress and Challenges
por: Lu, Yicheng, et al.
Publicado: (2023)

Exosomes as Drug Carriers in Anti-Cancer Therapy
por: Chen, Lan, et al.
Publicado: (2022)

Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration
por: Lu, Ye, et al.
Publicado: (2023)

Dual role of nanoparticles as drug carrier and drug
por: Patra, Hirak Kumar, et al.
Publicado: (2011)

Exosomes: potential diagnostic markers and drug carriers for adenomyosis
por: Cheng, Wen-Xiu, et al.
Publicado: (2023)

Research Advances of Engineered Exosomes as Drug Delivery Carrier
por: Huang, Lianghui, et al.
Publicado: (2023)

Engineering exosomes for targeted drug delivery
por: Liang, Yujie, et al.
Publicado: (2021)

T cell-derived exosomes in tumor immune modulation and immunotherapy
por: Zhou, Qiujun, et al.
Publicado: (2023)

Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma
por: Galardi, Angela, et al.
Publicado: (2023)

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
por: Mahaweni, Niken M., et al.
Publicado: (2013)

Development of Photo-Activated ROS-Responsive Nanoplatform as a Dual-Functional Drug Carrier in Combinational Chemo-Photodynamic Therapy
por: Chang, Yu-Cheng, et al.
Publicado: (2019)

Targeted acetylcholinesterase-responsive drug carriers with long duration of drug action and reduced hepatotoxicity
por: Lin, Yulong, et al.
Publicado: (2019)

Exosomes may be the carrier of acupuncture treatment for major depressive disorder
por: Lyu, Qin, et al.
Publicado: (2023)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
por: Zhang, Huan, et al.
Publicado: (2023)

Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma
por: Tian, Bao-Wen, et al.
Publicado: (2022)

Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies
por: Fu, Wei, et al.
Publicado: (2022)

The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System
por: Li, Tianwei, et al.
Publicado: (2022)

Exosomal PD-L1: an effective liquid biopsy target to predict immunotherapy response
por: Song, Yanling, et al.
Publicado: (2019)

Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung()
por: Popowski, Kristen D., et al.
Publicado: (2022)

Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2022)

Endogenous Lipid Carriers—Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes
por: Richards, Terjahna, et al.
Publicado: (2023)

Exosomes as Carriers of Alzheimer's Amyloid-ß
por: Yuyama, Kohei, et al.
Publicado: (2017)

Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
por: Antimisiaris, Sophia G., et al.
Publicado: (2018)

Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo
por: Deng, Wentao, et al.
Publicado: (2018)

Exosomal cancer immunotherapy is independent of MHC molecules on exosomes
por: Hiltbrunner, Stefanie, et al.
Publicado: (2016)

Prospects for exosomes in immunotherapy of cancer
por: Mignot, G, et al.
Publicado: (2006)

Exosomes in cancer immunoediting and immunotherapy
por: Zhao, Yarong, et al.
Publicado: (2022)

The Potential of Exosomes in Allergy Immunotherapy
por: Engeroff, Paul, et al.
Publicado: (2022)

The role of exosomal PD-L1 in tumor progression and immunotherapy
por: Xie, Feiting, et al.
Publicado: (2019)

Exosome regulation of immune response mechanism: Pros and cons in immunotherapy
por: Essola, Julien Milon, et al.
Publicado: (2023)

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
por: Xue, Jian, et al.
Publicado: (2021)

Preparation of Immunotherapy Liposomal-Loaded Thermal-Responsive Hydrogel Carrier in the Local Treatment of Breast Cancer
por: Tsai, Hsieh-Chih, et al.
Publicado: (2019)

Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
por: Yang, Fan, et al.
Publicado: (2021)

Development of Drug Dual-Carriers Delivery System with Mitochondria-Targeted and pH/Heat Responsive Capacity for Synergistic Photothermal-Chemotherapy of Ovarian Cancer
por: Guo, Xiaoxia, et al.
Publicado: (2020)

Combination of RCA and DNAzyme for Dual-Signal Isothermal Amplification of Exosome RNA
por: Xia, Yuqing, et al.
Publicado: (2023)

Combination of drugs and carriers in drug delivery technology and its development
por: Du, Ying, et al.
Publicado: (2019)

Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols
por: Muralidharan, Priya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_icuic4hj4e28ci107sbk5sl5vn